{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:04:49Z","timestamp":1794002689279,"version":"4.8.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,4,16]],"date-time":"2010-04-16T00:00:00Z","timestamp":1271376000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1745-6215-11-40","type":"journal-article","created":{"date-parts":[[2010,4,16]],"date-time":"2010-04-16T18:13:58Z","timestamp":1271441638000},"source":"Crossref","is-referenced-by-count":249,"title":["The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial"],"prefix":"10.1186","volume":"11","author":[{"given":"Haleema","family":"Shakur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Elbourne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metin","family":"G\u00fclmezoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zarko","family":"Alfirevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Ronsmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,4,16]]},"reference":[{"key":"451_CR1","volume-title":"Maternal Mortality in 2005. Estimates developed by WHO, UNICEF, UNFPA, and The World Bank. Geneva","author":"World Health Organization","year":"2007","unstructured":"World Health Organization, U.N.C.F, United Nations Population Fund, World Bank: Maternal Mortality in 2005. Estimates developed by WHO, UNICEF, UNFPA, and The World Bank. Geneva. 2007, The World Health Organisation, http:\/\/www.who.int\/reproductive-health\/publications\/maternal_mortality_2005\/mme_2005.pdf"},{"key":"451_CR2","first-page":"165","volume-title":"Antepartum and Postpartum Haemorrhage, in Health Dimensions of Sex and Reproduction","author":"C AbouZahr","year":"1998","unstructured":"AbouZahr C: Antepartum and Postpartum Haemorrhage, in Health Dimensions of Sex and Reproduction. Edited by: Murray, Lopez J, Boston A. 1998, Harvard School of Public Health on behalf of the World Health Organisation and the World Bank, 165-187. 1"},{"issue":"3","key":"451_CR3","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ijgo.2006.04.016","volume":"94","author":"A Lalonde","year":"2006","unstructured":"Lalonde A: Postpartum hemorrhage today: ICM\/FIGO initiative 2004-2006. Int J Gynaecol Obstet. 2006, 94 (3): 243-53. 10.1016\/j.ijgo.2006.04.016.","journal-title":"Int J Gynaecol Obstet"},{"issue":"9542","key":"451_CR4","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/S0140-6736(06)69380-X","volume":"368","author":"C Ronsmans","year":"2006","unstructured":"Ronsmans C, Graham WJ: Maternal mortality: who, when, where, and why. Lancet. 2006, 368 (9542): 1189-200. 10.1016\/S0140-6736(06)69380-X.","journal-title":"Lancet"},{"issue":"1","key":"451_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.whi.2008.09.008","volume":"19","author":"EJ Kongnyuy","year":"2009","unstructured":"Kongnyuy EJ, Mlava G, Broek van den N: Facility-based maternal death review in three districts in the central region of Malawi: an analysis of causes and characteristics of maternal deaths. Womens Health Issues. 2009, 19 (1): 14-20. 10.1016\/j.whi.2008.09.008.","journal-title":"Womens Health Issues"},{"issue":"9516","key":"451_CR6","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/S0140-6736(06)68397-9","volume":"367","author":"KS Khan","year":"2006","unstructured":"Khan KS: WHO analysis of causes of maternal death: a systematic review. Lancet. 2006, 367 (9516): 1066-74. 10.1016\/S0140-6736(06)68397-9.","journal-title":"Lancet"},{"issue":"3","key":"451_CR7","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/j.1471-0528.1997.tb11454.x","volume":"104","author":"AJ Ekeroma","year":"1997","unstructured":"Ekeroma AJ, Ansari A, Stirrat GM: Blood transfusion in obstetrics and gynaecology. Br J Obstet Gynaecol. 1997, 104 (3): 278-84.","journal-title":"Br J Obstet Gynaecol"},{"key":"451_CR8","first-page":"1","volume-title":"Global Database on Blood Safety","author":"World Health Organisation","year":"2001","unstructured":"World Health Organisation: Global Database on Blood Safety. 2001, WHO. Geneva, 1-32."},{"key":"451_CR9","volume-title":"Serious Hazards of Transfusion Annual Report 2007","author":"C Taylor","year":"2007","unstructured":"Taylor C: Serious Hazards of Transfusion Annual Report 2007. 2007, SHoTS Commitee. London (UK); 2008"},{"key":"451_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/bmb\/ldg015","volume":"67","author":"C AbouZahr","year":"2003","unstructured":"AbouZahr C: Global burden of maternal death and disability. Br Med Bull. 2003, 67: 1-11. 10.1093\/bmb\/ldg015.","journal-title":"Br Med Bull"},{"key":"451_CR11","volume-title":"The prevalence of anaemia in women: a tabulation of available information. WHO\/MCH\/MSM\/92.2","author":"World Health Organization","year":"1992","unstructured":"World Health Organization: The prevalence of anaemia in women: a tabulation of available information. WHO\/MCH\/MSM\/92.2. 1992, http:\/\/whqlibdoc.who.int\/hq\/1992\/WHO_MCH_MSM_92.2.pdf"},{"issue":"6","key":"451_CR12","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.2165\/00003495-199957060-00017","volume":"57","author":"CJ Dunn","year":"1999","unstructured":"Dunn CJ, Goa KL: Tranexamic acid: a review of its use in surgery and other indications. Drugs. 1999, 57 (6): 1005-32. 10.2165\/00003495-199957060-00017.","journal-title":"Drugs"},{"key":"451_CR13","volume-title":"Clinical Guidance","author":"National Collaborating Centre for Womens and Childrens Health","year":"2007","unstructured":"National Collaborating Centre for Womens and Childrens Health: Intrapartum care of healthy women and their babies during childbirth. Clinical Guidance. 2007, RCGO Press"},{"key":"451_CR14","volume-title":"BMC Pregnancy Childbirth manuscript ID","author":"PR Ferrer","year":"4090955672420008","unstructured":"Ferrer PR, Sydenham EI, Blackhall K, Shakur H: Anti-Fibrinolytic Agents in Obstetric Haemorrhage: A Systematic Review. BMC Pregnancy Childbirth manuscript ID. 4090955672420008,"},{"issue":"8876","key":"451_CR15","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/0140-6736(93)91945-I","volume":"342","author":"D Ketley","year":"1993","unstructured":"Ketley D, Woods KL: Impact of clinical trials on clinical practice: example of thrombolysis for acute myocardial infarction. Lancet. 1993, 342 (8876): 891-4. 10.1016\/0140-6736(93)91945-I.","journal-title":"Lancet"},{"key":"451_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1136\/jcp.33.Suppl_14.35","volume":"14","author":"CR Prentice","year":"1980","unstructured":"Prentice CR: Basis of antifibrinolytic therapy. J Clin Pathol Suppl (R Coll Pathol). 1980, 14: 35-40.","journal-title":"J Clin Pathol Suppl (R Coll Pathol)"},{"issue":"2","key":"451_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1055\/s-2003-38897","volume":"29","author":"M Hellgren","year":"2003","unstructured":"Hellgren M: Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost. 2003, 29 (2): 125-30. 10.1055\/s-2003-38897.","journal-title":"Semin Thromb Hemost"},{"key":"451_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1136\/jcp.33.Suppl_14.55","volume":"14","author":"J Bonnar","year":"1980","unstructured":"Bonnar J: Clinical applications of fibrinolytic inhibition in gynaecology. J Clin Pathol Suppl (R Coll Pathol). 1980, 14: 55-9.","journal-title":"J Clin Pathol Suppl (R Coll Pathol)"},{"key":"451_CR19","first-page":"364","volume":"1279","author":"AC Bolte","year":"2005","unstructured":"Bolte AC, Bouma L, van Geijn HP: Medical therapies for primary postpartum hemorrhage. International Congress Series. Gynaecology, Obstetrics, and Reproductive Medicine in Daily Practice. 2005, 1279: 364-368.","journal-title":"International Congress Series. Gynaecology, Obstetrics, and Reproductive Medicine in Daily Practice"},{"key":"451_CR20","doi-asserted-by":"crossref","unstructured":"Henry DA: Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2007, CD001886-4","DOI":"10.1002\/14651858.CD001886.pub2"},{"issue":"5 Pt 1","key":"451_CR21","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/S0029-7844(99)00426-3","volume":"94","author":"RB Gherman","year":"1999","unstructured":"Gherman RB: Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy. Obstet Gynecol. 1999, 94 (5 Pt 1): 730-4. 10.1016\/S0029-7844(99)00426-3.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"451_CR22","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S0029-7844(99)00308-7","volume":"94","author":"P Lindqvist","year":"1999","unstructured":"Lindqvist P, Dahlback B, Marsal K: Thrombotic risk during pregnancy: a population study. Obstet Gynecol. 1999, 94 (4): 595-9. 10.1016\/S0029-7844(99)00308-7.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"451_CR23","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1056\/NEJM199607113350207","volume":"335","author":"MR Toglia","year":"1996","unstructured":"Toglia MR, Weg JG: Venous thromboembolism during pregnancy. N Engl J Med. 1996, 335 (2): 108-14. 10.1056\/NEJM199607113350207.","journal-title":"N Engl J Med"},{"issue":"10","key":"451_CR24","doi-asserted-by":"publisher","first-page":"697","DOI":"10.7326\/0003-4819-143-10-200511150-00006","volume":"143","author":"JA Heit","year":"2005","unstructured":"Heit JA: Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med. 2005, 143 (10): 697-706.","journal-title":"Ann Intern Med"},{"key":"451_CR25","unstructured":"Summary of Product Characteristics for Cyklokapron. accessed 19\/01\/09, http:\/\/emc.medicines.org.uk\/emc\/assets\/c\/html\/displaydoc.asp?documentid=1489"},{"issue":"7167","key":"451_CR26","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1136\/bmj.317.7167.1170","volume":"317","author":"R Peto","year":"1998","unstructured":"Peto R, Baigent C: Trials: the next 50 years. Large scale randomised evidence of moderate benefits. BMJ. 1998, 317 (7167): 1170-1.","journal-title":"BMJ"},{"issue":"2","key":"451_CR27","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/00000542-199502000-00009","volume":"82","author":"JC Horrow","year":"1995","unstructured":"Horrow JC: The dose-response relationship of tranexamic acid. Anesthesiology. 1995, 82 (2): 383-92. 10.1097\/00000542-199502000-00009.","journal-title":"Anesthesiology"},{"issue":"9460","key":"451_CR28","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/S0140-6736(05)70939-9","volume":"365","author":"DAMOCLES Study Group","year":"2005","unstructured":"DAMOCLES Study Group: A proposed charter for clinical trial data monitoring committees: helping them to do their job well. Lancet. 2005, 365 (9460): 711-22.","journal-title":"Lancet"},{"issue":"526","key":"451_CR29","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1259\/0007-1285-44-526-793","volume":"44","author":"JL Haybittle","year":"1971","unstructured":"Haybittle JL: Repeated assessment of results in clinical trials of cancer treatment. Br J Radiol. 1971, 44 (526): 793-7. 10.1259\/0007-1285-44-526-793.","journal-title":"Br J Radiol"},{"issue":"1","key":"451_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/bjc.1977.1","volume":"35","author":"R Peto","year":"1977","unstructured":"Peto R: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977, 35 (1): 1-39.","journal-title":"Br J Cancer"},{"key":"451_CR31","doi-asserted-by":"crossref","unstructured":"Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication (Updated October 2008). on 1st May, 2009, http:\/\/www.icmje.org\/","DOI":"10.3329\/bsmmuj.v1i1.3699"},{"issue":"7","key":"451_CR32","first-page":"658","volume":"25","author":"D Moher","year":"2005","unstructured":"Moher D, Schulz KF, Altman DG: [The CONSORT statement: Revised Recommendations For Improving the Quality of Reports of Parallel-Group Randomized Trials]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2005, 25 (7): 658-61.","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1745-6215-11-40\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-11-40.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-11-40","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-11-40.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T13:04:47Z","timestamp":1559048687000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/1745-6215-11-40"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,16]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["451"],"URL":"https:\/\/doi.org\/10.1186\/1745-6215-11-40","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,16]]},"article-number":"40"}}